Almirall is a family-owned company from Barcelona – based in Europe, investing in Europe. We are building a pipeline 100% focused on dermatology. With our 80-year-old history, Almirall doesn´t think in quarters but in generations. Almirall Nordic has a clear commitment to the dermatology community; to collaborate with scientists and healthcare professionals to address patients’ needs through science. Our goal is to be a Nordic lighthouse within medical dermatology, with a clear ambition to offer solutions used every day at the dermatologist’s office.
Galderma is the emerging pure-play dermatology category leader, present in approximately 90 countries. We deliver an innovative, science-based portfolio of premium flagship brands and services that span the full spectrum of the fast-growing dermatology market though Injectable Aesthetics, Dermatological Skincare and Therapeutic Dermatology. Since our foundation in 1981, we have dedicated our focus and passion to the human body’s largest organ – the skin – meeting individual consumer and patient needs with superior outcomes in partnership with healthcare professionals.
Sanofi is an innovative global healthcare company, driven by one purpose: we chase the miracles of science to improve people’s lives. Sanofi’s teams, across some 100 countries, are dedicated to transforming the practice of medicine by working to turn the impossible into the possible. We provide potentially life-changing treatment options and life-saving vaccine protection to millions of people globally, while putting sustainability and social responsibility at the center of our ambitions.
Gold Sponsors
One of the biggest pharmaceutical companies in the world, AbbVie develops new therapies for serious illnesses, focusing on immunological and neurological conditions, oncological and haematological conditions and eye disorders. Our mission is to improve the quality of life of those living with serious illnesses. We also aim to provide healthcare professionals with best in class medicinal solutions utilizing new mechanisms of action. Our motto, Focus on people, summarizes our patient centred approach.
Johnson & Johnson is among the world’s largest research and development pharmaceutical companies. Janssen operates in over 150 countries. Our future goal is to make diseases a thing of the past by detecting them even before the first symptoms appear. We focus our efforts where we can save the most lives or improve people’s quality of life. Currently, our core areas of focus are immunology, vaccines, neuroscience, and oncology.
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
UCB is a global biopharmaceutical company dedicated to discovering and developing innovative medicines that transform patients’ lives. We are committed to putting patients at the centre of our world, with a focus on immunology, including psoriasis, psoriatic arthritis, and hidradenitis suppurativa. www.ucb.com